YANG Dajun, Chairman of the Board and CEO, Ascentage Pharma
14:00 - 14:25
主题报告1
Keynote Speech1
创新分子靶向药物Ras抑制剂治疗胰腺癌研究进展
Research Progress on Innovative Molecularly Targeted Ras Inhibitors for the Treatment of Pancreatic Cancer
秦叔逵, 中国药促会抗肿瘤专委会主委，浙江钱塘高等研究院钱塘学者兼临床肿瘤研究所所长
QIN Shukui, Chairman of Anti-Tumor Committee of PhIRDA,
Qiantang Scholar at Zhejiang Qiantang Advanced Research Institute, and Director of the Clinical Oncology Research Institute
14:25 - 14:50
主题报告2
Keynote Speech2
创新迭代下的乳腺癌全病程管理新格局
A New Pattern of Whole-Course Management of Breast Cancer under Innovation and Iteration
殷咏梅, 中国药促会抗肿瘤专委会副主委，江苏省人民医院副院长
YIN Yongmei, Deputy Director of Anti-Tumor Committee of PhIRDA,
Vice President of Jiangsu Province Hospital
14:50 - 15:40
第二阶段：主题报告
Session II：Keynote Speech
主持人 Moderator
李源培, 赛麦德咨询亚太区副总裁
Ryan LI, Asia Vice President, SAI
14:50 - 15:15
主题报告3
Keynote Speech3
肿瘤治疗性mRNA疫苗的临床突破
Clinical Breakthroughs in Therapeutic mRNA Vaccines for Tumors
回爱民, 惠正奇医药（广州）有限公司创始人、董事长兼CEO
HUI Aimin, Founder, Chairman and CEO of EnCureGen Pharma Guangzhou Limited
15:15 - 15:40
主题报告4
Keynote Speech4
抗肿瘤新药国际监管新趋势
New International Regulatory Trends for Antitumor Drugs
李长青, 深圳埃格林医药有限公司联合创始人兼首席医学官
LEE CHANG, Co-founder & CMO, Shenzhen Evergreen Therapeutics Co., Ltd.
15:40 - 17:00
第三阶段：主题讨论
Session III: Panel
15:40 - 16:20
主题讨论1
Panel1
抗肿瘤药物研发源头创新突破
Breakthroughs in Original Innovation for Antitumor Drug Research and Development
主持人 Moderator
郭彤, 中国药促会抗肿瘤专委会顾问，高博医疗集团临床研究中心首席执行官
GUO Tong, Advisor of Anti-tumor Committee of PhIRDA,
CEO, Clinical Research Center, G-Bio Health Group
会议咨询